Syndax Announces Presentation at 41st Annual J.P. Morgan Healthcare Conference

/PRNewswire/ -- Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies,...

Related Keywords

Sharon Klahre ,Michaela Metzger ,Linkedin ,Company On Twitter ,Prnewswire Syndax Pharmaceuticals Inc ,Syndax Pharmaceuticals Inc ,Syndax Pharmaceuticals ,Nasdaq ,Chief Executive Officer ,Healthcare Conference ,Nc ,